1. Home
  2. LAKE vs GNLX Comparison

LAKE vs GNLX Comparison

Compare LAKE & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakeland Industries Inc.

LAKE

Lakeland Industries Inc.

HOLD

Current Price

$9.61

Market Cap

122.0M

Sector

Health Care

ML Signal

HOLD

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$1.95

Market Cap

110.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAKE
GNLX
Founded
1982
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
122.0M
110.4M
IPO Year
2013
2022

Fundamental Metrics

Financial Performance
Metric
LAKE
GNLX
Price
$9.61
$1.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$15.25
★ $18.83
AVG Volume (30 Days)
89.3K
★ 294.3K
Earning Date
12-08-2026
11-04-2026
Dividend Yield
★ 0.33%
N/A
EPS Growth
N/A
★ 9.47
EPS
N/A
★ N/A
Revenue
★ $192,648,000.00
$8,000.00
Revenue This Year
$3.47
N/A
Revenue Next Year
$8.33
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 15.21
N/A
52 Week Low
$7.15
$1.96
52 Week High
$17.72
$8.54

Technical Indicators

Market Signals
Indicator
LAKE
GNLX
Relative Strength Index (RSI) 44.27 28.58
Support Level $9.25 N/A
Resistance Level $9.67 $2.80
Average True Range (ATR) 0.55 0.18
MACD -0.02 -0.06
Stochastic Oscillator 20.40 6.16

Price Performance

Historical Comparison
LAKE
GNLX

About LAKE Lakeland Industries Inc.

Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe, and Other Foreign. It generates the majority of its revenue from the United States.

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Share on Social Networks: